• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
  • Activism
  • Animal Testing
  • Artificial Intelligence
  • Boeing 737
  • Brexit
  • Cannabis
  • Censorship
  • Climate
  • Coal
  • COVID-19
  • Criminal
  • Death
  • Debt Markets
  • Derivatives
  • Diversity
  • Economy
  • Electric Vehicles
  • Electricity Generation
  • Ethanol
  • Financial
  • Firearms
  • Fossil Fuels
  • Glyphosate
  • Harassement
  • Immigration
  • Information Security
  • Intellectual Property
  • Interest Rates
  • Labor
  • Layoff
  • Lead
  • Legal
  • Palm Oil
  • Pension
  • Political
  • Product Safety
  • Regulatory
  • Religion
  • Securities Market
  • Supply Chain
  • Tariff
  • Textiles
  • US Equities
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Kaplan Fox Encourages Investors of Beta Bionics, Inc. (NASDAQ: BBNX) to Contact the Firm to Learn About Their Legal Rights
September 09, 2026
Via NewMediaWire
Topics Lawsuit
Tickers BBNX
Exposures Financial Legal Product Safety
News headline image
Kaplan Fox Encourages Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors Seeking Recovery to Contact the Firm Before September 28, 2026
September 09, 2026
Via NewMediaWire
Topics Lawsuit
Tickers BAC CAPR
Exposures Financial Legal Product Safety
News headline image
FDA Issues Complete Response Letter for AbbVie’s Fast-Acting Neurotoxin TrenibotE; Spokane dermatologist Dr. Philip Werschler on What the Letter Means ↗
September 09, 2026
Via Talk Markets
Exposures Product Safety
News headline image
What Running Dozens of Simultaneous Clinical Trials Revealed About How Medicine Actually Gets Made: Dr. Phil Werschler on the Research Behind the Results ↗
September 09, 2026
Via Talk Markets
Exposures Product Safety
News headline image
Nova Warranty Addresses Coverage Gaps for Mercedes-Benz Owners Following Largest Recall Year
September 09, 2026
Via Press Advantage
Topics Product Recall
Exposures Legal Product Safety
News headline image
Qscription Technologies and NEOPATHOLOGY CORP. Sign MOU to Bring FDA-Cleared Lung Imaging AI into U.S. Clinical Practice
September 09, 2026
Via PRLog
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
News headline image
Kaplan Fox Announces an Investigation Into Medline Inc. (NASDAQ: MDLN) for Potential Securities Law Violations
September 09, 2026
Via NewMediaWire
Tickers BAC MDLN
Exposures Product Safety
News headline image
Gene Therapy at Lower Dose Shows Vision Improvements, Opus Genetics Says ↗
September 09, 2026
Via Benzinga
Exposures Product Safety
News headline image
Kaplan Fox Alerts Fulcrum Therapeutics, Inc. (NASDAQ: FULC) Investors to an Ongoing Investigation Into Possible Securities Law Violations
September 09, 2026
Via NewMediaWire
Tickers FULC
Exposures Product Safety
BioMedNewsBreaks — Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Featured in BioMedWire Editorial Following FDA Clearance for Lucid-MS Phase 2 Trial
September 09, 2026
Via Investor Brand Network
Tickers CSE:QNTM QNTM
Exposures Product Safety
News headline image
Intelligent Bio Submits Comprehensive Clinical Data to Enter US Drug Screening Market ↗
September 09, 2026
Via Benzinga
Exposures Product Safety
News headline image
Lovegra 100 mg (Sildenafil): Safety, Risks & Medical Guidance ↗
September 09, 2026
Via Talk Markets
Exposures Product Safety
News headline image
Vinod Khosla Calls on FDA to Certify AI That Outperforms the 'Median Human Doctor' ↗
September 09, 2026
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
News headline image
Companion Diagnostics Market Size, Trends, and Growth Analysis 2026-2033 ↗
September 09, 2026
Via Talk Markets
Exposures Product Safety
News headline image
Kaplan Fox Encourages Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to Contact the Firm Before the Lead Plaintiff Deadline on September 28, 2026
September 08, 2026
Via NewMediaWire
Topics Lawsuit
Tickers BAC CAPR
Exposures Financial Legal Product Safety
News headline image
San Diego Probation Violations Attorney: Criminal Defense Law Services Announced
September 08, 2026
Via Press Release Distribution Service
Topics Product Recall
Exposures Legal Product Safety
News headline image
Kaplan Fox Reminds Investors of Capricor Therapeutics, Inc. (NASDAQ: CAPR) to a Securities Class Action Deadline - Contact the Firm Before September 28, 2026
September 08, 2026
Via NewMediaWire
Topics Lawsuit
Tickers BAC CAPR
Exposures Financial Legal Product Safety
News headline image
Astrazeneca Secures FDA Approval for New Breast Cancer Treatment ↗
September 08, 2026
Via Benzinga
Exposures Product Safety
News headline image
Where Will CRISPR Therapeutics Stock Be in 5 Years? ↗
September 08, 2026
Via The Motley Fool
Tickers CRSP VRTX
Exposures Product Safety
A Micro-Cap Biotech Just Cleared a Milestone Most Never Reach
September 08, 2026
Via Investor Brand Network
Tickers BIIB BMWYY QNTM RHHBY SNY
Exposures Product Safety
InvestorNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Gains Editorial Spotlight Following FDA Clearance for Lucid-MS Phase 2 Trial
September 08, 2026
Via Investor Brand Network
Tickers BIIB CLNN CSE:QNTM QNTM RHHBY SNY
Exposures Product Safety
MissionIRNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Gains Editorial Spotlight Following FDA Clearance for Lucid-MS Phase 2 Trial
September 08, 2026
Via Investor Brand Network
Tickers BIIB CLNN CSE:QNTM QNTM RHHBY SNY
Exposures Product Safety
News headline image
Beam Therapeutics Targets Accelerated FDA Approval for Base-Editing Treatment ↗
September 08, 2026
Via Benzinga
Exposures Product Safety
News headline image
MiniMed (MMED) Q1 2027 Earnings Call Transcript ↗
September 08, 2026
Via The Motley Fool
Topics Earnings
Tickers MMED
Exposures Financial Product Safety
News headline image
Echocardiography Market Size, Trends, and Growth Forecast 2026-2033 ↗
September 08, 2026
Via Talk Markets
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence COVID-19 Product Safety
News headline image
Helio Peptides Review: Exploring Quality and Research Standards ↗
September 08, 2026
Via Talk Markets
Topics Supply Chain
Exposures Product Safety Supply Chain
News headline image
Youth Tobacco Use Is at Historic Lows. Adult Smokers Still Need Better Choices.
September 08, 2026
Via NewsUSA
Exposures Product Safety
News headline image
Maye Musk Recounts 'Strange' Experience With Tesla's Cybercab Without a Steering Wheel And Pedals in 2024 Amid Austin Rollout: 'It Will Free Up…' ↗
September 06, 2026
Via Benzinga
Topics Product Recall
Tickers TSLA
Exposures Legal Product Safety
News headline image
Gilead Sciences Just Won Its Third FDA Approval in Less Than 4 Months. Is the Stock Still Underrating This Turnaround Play? ↗
September 05, 2026
Via The Motley Fool
Tickers GILD
Exposures Product Safety
News headline image
Kaplan Fox Alerts Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to Seek Leadership in a Securities Fraud Lawsuit by September 28, 2026
September 04, 2026
Via NewMediaWire
Topics Fraud Lawsuit
Tickers BAC CAPR
Exposures Financial Legal Product Safety
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap